pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,551
stories
8d
Pfizer snags $1.5B financing from PE firm Blackstone to support Metsera asset
biospace
8d
ARPA-H bets $4.9 million on ibogaine for PTSD treatment in veterans
fiercebiotech
8d
Experts update prostate cancer screening guidelines for men
stat
9d
Kyverna abandons next-gen autoimmune CAR-T once touted as follow-up to miv-cel
fiercebiotech
9d
Pfizer taps Blackstone for up to $1.5B to pave path to GLP-1's obesity launch
fiercebiotech
9d
Recon: FDA shelves commissioner's voucher program; Eli Lilly gets first GLP-1 weight-loss pill approved in China
raps
9d
Euro Roundup: EMA posts draft guideline on approval dossiers for biomarker-guided therapies
raps
9d
STAT+: Most-favored nations policy makes drugmakers rethink launches abroad
stat
9d
FDA warns Chinese providers of compounding APIs over record-request refusals
biospace
9d
Capricor parts ways with 10% of staff as FDA decision on DMD cell therapy nears
biospace
9d
STAT+: Cassidy sets key vote on Overton, even as he remains undecided on nominee to lead FDA
stat
9d
Capricor ramps up manufacturing spend ahead of FDA decision for DMD therapy
biospace
9d
STAT+: Pharmalittle: We’re reading about Dems eyeing Trump MFN deals, fewer drug launches in Europe, and more
stat
9d
AstraZeneca buys vaccine startup; FDA issues GLP-1 safety warning
biopharma dive
9d
The U.S. may soon lose measles elimination status
stat
9d
Merck KGaA lands FDA nod for joint tumor drug it licensed from Abbisko
endpoints
10d
Novartis’ Zolgensma woes, BIO’s China plan, GLP-1s’ new safety warning, FDA’s stacked November
biospace
10d
BioNTech pays $205M for FDA voucher to speed up ‘late-stage oncology pipeline’
fiercebiotech
10d
Capricor, NextCure shed light on recent layoffs as they gear up for approval decision, merger
fiercebiotech
10d
Abbott nabs FDA approval, CE Mark for implantable cardioverter-defibrillator lead
fiercebiotech
10d
FDA's rare disease framework faces its first real test in Capricor’s DMD drug
biospace
10d
STAT+: Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug
stat
10d
STAT+: Oura to acquire Counsel Health for $625 million, placing a big bet on AI care
stat
10d
Beam’s base editing therapy for sickle cell hits goal in pivotal trial
biopharma dive
10d
Beam preps FDA run for industry-first base-edited therapy after pivotal sickle cell success
biospace
10d
Bayer wins first-in-class FDA nod for blood thinner, setting stage for BMS-J&J rival
biospace
10d
Delix raises $100M to advance at-home psychedelic without hallucinogenic effects
biospace
10d
Delix raises $100M to advance at-home psychedelic without hallucinatory effects
biospace
10d
STAT+: Pharmalittle: We’re reading about an approval for novel drug for strokes, a warning for GLP-1 drugs, and more
stat
11d
BIO unveils plan for US to remain biotech’s ‘global leader’
biopharma dive
← prev
page 4 of 52
next →